High antibiotic susceptibility among bacterial pathogens in Swedish ICUs

Scandinavian Journal of Infectious Diseases

Volumn 36, Issue 1, 2004, Pages 24-30

  Hanberger, Håkan ^a   Erlandsson, Marcus ^a   Burman, Lars G ^b   Cars, Otto ^b   Gill, Hans ^a   Lindgren, Sune ^a   Nilsson, Lennart E ^a   Olsson Liljequist, Barbro ^b   Walther, Sten ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN; CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; IMIDAZOLE; IMIPENEM; MACROLIDE; METICILLIN; NETILMICIN; OXACILLIN; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TETRACYCLINE; TRIAZOLE; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DEMOGRAPHY; DISINFECTION; DRUG USE; ENTEROBACTER; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; HAND WASHING; HEALTH CARE FACILITY; HOSPITAL BED; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; KLEBSIELLA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; PATHOGENICITY; PSEUDOMONAS AERUGINOSA; SERRATIA; SOUTHERN EUROPE; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; SWEDEN; UNITED STATES;

ADULT; ANTI-BACTERIAL AGENTS; COHORT STUDIES; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROBABILITY; QUESTIONNAIRES; RETROSPECTIVE STUDIES; RISK FACTORS; SWEDEN;

EID: 1242296972     PISSN: 00365548     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365540310017429     Document Type: Article

References (33)

1. Hanberger H, Nilsson LE and the SCOPE study Group. Higher incidence of antibiotic resistance among nosocomial bacteria in Nordic intensive care units (ICUs) compared to primary care centres. In: Abstracts of the 3rd European Congress of Chemotherapy, Madrid, Abstract T 136, 2000.
2. Archibald L, Phillips L, Monnet D, McGowan JE, Tenover F, Gaynes R. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: increasing importance of the intensive care unit. Clin Infect Dis 1997; 24: 211-5.
3. Hanberger H, Diekema D, Fluit A, Jones R, Struelens M, Spencer R, Wolff M. J Hosp Infect 2001; 48: 161-76.
4. Vincent JL, Bihari DJ, Suter PM, Bruining HA, White J, Nicolas-Chanoin M-H. et al. The prevalence of nosocomial infection in intensive care units in Europe. JAMA 1995; 274: 639-44.
5. Regnier B. Epidemiology of control of antibiotic multiresistant bacteria in hospitals. (In French.) Path Biol 1996; 44:113-23.
6. Burwen DR, Banerjee SN, Gaynes RP and the National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial Gram-negative bacilli in the United States. J Infect Dis 1994; 170: 1622-5.
7. Diekema DJ, Pfaller MA, Jones RN, Doern GV, Winokur PL, Gales AC, et al. and the SENTRY participants group (Americas). Survey of bloodstream infections due to Gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada and Latin America for the Sentry antimicrobial surveillance programme. Clin Infect Dis 1997; 199; 29; 595-607.
8. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a 3-y analysis. Clin Infect Dis 1999; 29: 239-44.
9. Erlandsson CM, Hanberger H, Eliasson I, Hoffmann M, Isaksson B, Lindgren S, et al. Surveillance of antibiotic resistance in ICUs in southeastern Sweden. Acta Anaesthesiol Scand 1999; 43: 815-20.
10. Walther SM, Erlandsson M, Burman LG, Cars O, Gill H, Hoffman M, et al. Icustrama Study Group. Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiol Scand. 2002; 46(9): 1075-81.
11. Aksaray S, Dokuzoguz, Guvener E, Yucesoy M, Yulug N, Kocagoz S, et al. Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in 8 hospitals in Turkey. J Antimicrob Chemother 2000; 45: 695-9.
12. Cars O, Mölstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-3.
13. Hanberger H, Nilsson LE, Claesson B, Karnell A, Larsson P, Rylander M, et al. New species-related MIC breakpoints for early detection of development of resistance among Gram-negative bacteria in Swedish intensive care units. J Antimicrob Chemother 1999; 611-19.
14. Olsson-Liljequist B, Larsson P, Wader M, Miörner H. Methodology for susceptibility testing. Scand J Infect Dis 105 1997; (suppl): S13-23.
15. Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, et al. Enterobacter bacteraemia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-90.
16. D'Agata E, Venkataram L, DeGirolami P, Samore M. Molecular epidemiology of acquisition of ceftazidime-resistant Gram-negative bacilli in a non-outbreak setting. J Clin Microbiol 1997; 5: 2602-5.
17. Mebis J, Goossens H, Bruyneel P, Sion JP, Meeus I, Van Droogenbroeck J, et al. Decreasing antibiotic resistance of Enterobacteriaceae by introducing a new antibiotic combination therapy for neutropenic fever patients. Leukemia 1998; 12: 1627-9.
18. Struelens MJ, Byl B, Govaerts D. Modification of antibiotic policy associated with decrease in antibiotic-resistant Gram-negative bacilli in an intensive care unit. Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, Abstract K-12, 1998.
19. Struelens MJ, Byl B, Vincent JL. Antibiotic policy: a tool for controlling resistance of hospital pathogens. Clin Microbiol Infect 1999; 5: S19-24.
20. Carmeli Y, Troillet N, Eliopoulos GM, Samore MH. Emergence of antibiotic-resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. Antimicrobial Agents Chemother 1999; 43: 1379-82.
21. Hanberger H, Garcia-Rodriguez JA, Gobernado M, Goossens H, Nilsson LE, Struelens MJ. Antibiotic susceptibility among aerobic Gram-negative bacilli in intensive care units. JAMA 1999; 281: 67-71.
22. Bergogne-Berezin E. The increasing significance of outbreaks of Acinetobacter spp: the need for control and new agents. Journal of Hospital Infection 1995; 30(suppl): S441-52.
23. Towner KJ. Clinical importance and antibiotic resistance of Acinetobacter spp. Journal of Medical Microbiology 1997; 46: 721-46.
24. Villers D, Espaze E, Coste-Burel M, Giauffret F, Ninin E, Nicolas F, Richet H. Nosocomial Acinetobacter baumannii infections: microbiological and clinical epidemiology. Annals of Internal Medicine 1998; 129: 182-9.
25. Lortholary O, Fagon JY, Hoi AB, Slama MA, Pierre J, Giral P, et al. Nosocomial acquisition of multiresistant Acinetobacter baumannii: risk factors and prognosis. Clinical Infectious Diseases 1995; 20: 90-6.
26. Blot S, Vandewoude K, Colardyn F. Nosocomial bacteraemia involving Acinetobacter baumanni in critically ill patients: a matched cohort study. Intensive Care Med 2003; 29: 471-5.
27. Rello J, Diaz E. Acinetobacter baumanni: a threat for the ICU? Intensive Care Med 2003; 29: 350-1.
28. Wood CA, Reboli AC. Infections caused by imipenem-resistant Acinetobacter calcoaceticus biotype anitratus. Journal of Infectious Diseases 1993; 168: 1602-3.
29. Go ES, Urban C, Burns J, Kreiswirth B, Eisner W, Mariano N, et al. Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994; 344: 1329-32.
30. Fridkin SK, Steward CD, Edwards JR, Pryor ER, McGowan Jr JE, Archibald LK, et al. Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: Project ICARE Phase 2. Clin Infect Dis 1999; 29: 245-52.
31. Hails J, Kwaku F, Wilson AP, Bellingan G, Singer M. Large variation in MRSA policies, procedures and prevalence in English intensive care units: a questionnaire analysis. Intensive Care Med 2003; 29: 481-3.
32. Verhoef J, Beaujean D, Blok H, Banta H, Meyler A, van der Werken C, Weersink A. A Dutch approach to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1999; 18: 461-6.
33. Bonten MJ, Mascini EM. The hidden faces of the epidemiology of antibiotic resistance. Intensive Care Med 2003; 29: 1-2.